Skip to Main Content

Paper Details

HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer.
Mod Pathol
1
2023
Author NameAffiliation
David N BrownMemorial Sloan Kettering Cancer Center
Arnaud Da Cruz PaulaMemorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Lora H EllensonMemorial Sloan Kettering Cancer Center
Britta WeigeltMemorial Sloan Kettering Cancer Center
  • 1 - 5

Datasets

Release 1.2